Skip to main content
. 2009 Jul 22;90(3):613–620. doi: 10.3945/ajcn.2008.27424

TABLE 3.

Cumulative long-chain omega-3 fatty acid intake and relative risk (RR) of diabetes mellitus in cohorts of women and men1

Long-chain omega-3 fatty acid intake
0 g/d >0–0.05 g/d >0.05–0.1 g/d >0.1–0.15 g/d >0.15–0.20 g/d >0.20–0.25 g/d >0.25–0.30 g/d >0.30–0.35 g/d >0.35–0.40 g/d >0.40 g/d P for trend
NHS
 No. of cases 199 616 695 626 548 401 323 246 124 381
 Person-years 57,079 159,077 182,188 152,265 128,511 99,660 74,118 50,237 33,514 85,159
 Multivariate-adjusted RR2 1 1.07 (0.91, 1.26) 1.06 (0.91, 1.25) 1.16 (0.98, 1.36) 1.23 (1.05, 1.46) 1.22 (1.03, 1.45) 1.32 (1.10, 1.58) 1.46 (1.21, 1.77) 1.12 (0.89, 1.40) 1.35 (1.13, 1.61) <0.001
NHS2
 No. of cases 214 552 558 412 305 221 166 112 54 134
 Person-years 108,711 260,136 254,730 187,893 134,230 988,802 70,684 44,008 28,204 66,859
 Multivariate-adjusted RR2 1 1.00 (0.86, 1.18) 1.03 (0.88, 1.21) 1.05 (0.89, 1.24) 1.12 (0.94, 1.34) 1.18 (0.98, 1.43) 1.28 (1.04, 1.58) 1.47 (1.17, 1.86) 1.07 (0.79, 1.45) 1.14 (0.91, 1.43) 0.006
HPFS
 No. of cases 98 225 283 259 228 252 226 208 155 559
 Person-years 28,012 59,984 79,702 69,957 64,280 69,200 65,326 51,510 42,185 147,861
 Multivariate-adjusted RR2 1 0.90 (0.73, 1.10) 0.92 (0.75, 1.12) 1.00 (0.81, 1.23) 0.90 (0.73, 1.10) 0.91 (0.74, 1.13) 1.02 (0.83, 1.26) 1.08 (0.87, 1.36) 1.01 (0.79, 1.28) 1.05 (0.86, 1.29) 0.04
1

NHS, Nurses' Health Study; NHS2, Nurses' Health Study 2; HPFS, Health Professionals Follow-Up Study.

2

Multivariate model adjusted for smoking (never, past, 1–14 cigarettes/d, 15–24 cigarettes/d, or >24 cigarettes/d); alcohol consumption (0, 0.1–4.9, 5.0–9.9, or ≥10 g/d); physical activity (quintiles; metabolic equivalent tasks/d); family history of diabetes mellitus; BMI (10 categories); intakes of saturated fat, trans fats, linolenic acid, linoleic acid, caffeine, and cereal fiber; glycemic index (all quintiles); and calories (quintiles). In the NHS, the multivariate models were also adjusted for menopausal status and postmenopausal hormone use. In the NHS2, the multivariate models were also adjusted for use of hormone replacement therapy (ever or never) and oral contraceptive use (never, past, or current).